Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of IL-6 in coronavirus, especially in COVID-19
Xinyi Wang, Guozheng Tang, Yuchen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Arwa A. Al-Qahtani, Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 1, pp. 13-13
Open Access | Times Cited: 69
COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction
Ekaterina Georgieva, Julian Ananiev, Y. Yovchev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14876-14876
Open Access | Times Cited: 52
Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases
Jiahui Wang, Yongjian Liu, Yushi Guo, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115973-115973
Closed Access | Times Cited: 21
Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems
Christina-Michailia Sideratou, Christos Papaneophytou
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 806-830
Open Access | Times Cited: 16
Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney
Verónica Miguel, C. Rey, Jessica Tituaña, et al.
Redox Biology (2023) Vol. 68, pp. 102957-102957
Open Access | Times Cited: 15
A novel nanocomposite drug delivery system for SARS-CoV-2 infections
Uday Chintapula, Shazeed-Ul Karim, Priyanka Raghunathan Iyer, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 15, pp. 3747-3758
Open Access | Times Cited: 6
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 5
Elevated interleukin-6 serum levels in pregnant women with coronavirus disease 2019
Dzatur R. SYARIFUDDIN, Isharyah Sunarno, Maisuri T. Chalid, et al.
Gazzetta Medica Italiana Archivio per le Scienze Mediche (2025) Vol. 183, Iss. 11
Closed Access
Immunothrombotic involvement in COVID-19
José A. Páramo, María Marcos‐Jubilar
Elsevier eBooks (2025), pp. 335-352
Closed Access
Hemostatic Profile and Serum Levels of Interferon Gamma-Induced Protein 10 (IP-10) in Neonates Born to Mothers with COVID-19 During the Peripartum Period
Rozeta Sokou, Efstathia-Danai Bikouli, Andreas G. Tsantes, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1201-1201
Open Access
Therapeutic JAK inhibition does not impact lung injury during viral or bacterial pneumonia in male mice
Lokesh Sharma, Rupa Singh, Caden Ngeow, et al.
Physiological Reports (2025) Vol. 13, Iss. 3
Open Access
Machine Learning Methods Based on Chest CT for Predicting the Risk of COVID-19-Associated Pulmonary Aspergillosis
Jiahao Liu, Juntao Zhang, Huaizhen Wang, et al.
Academic Radiology (2025)
Closed Access
Inflammatory biomarkers and adverse outcome in COVID-19: Prelude for future viral pandemics
Ankit Kumar, Sushma Yendamuri, Faiz Ahmad, et al.
Journal of Family Medicine and Primary Care (2025) Vol. 14, Iss. 2, pp. 720-728
Open Access
Nucleocapsid Protein of SARS-CoV-2 Upregulates RANTES Expression in A172 Glioblastoma Cells
Bakhytgul Gadilgereyeva, Zhanar Kunushpayeva, M. B. Abdrakhmanova, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1066-1066
Open Access
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases
Cristina Quecchia, Andrea Vianello
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2185-2185
Open Access
Interleukin-6 and Leukocyte Cell Population Data in Newly Diagnosed Sepsis—A Prospective Study
Sara Šundalić, Iva Košuta, Ivana Lapić, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 468-468
Open Access
Interleukin-6 regulates human ODAM gene expression in gingival epithelial cells
Zhenyu Jin, Arisa Yamaguchi, Hideki Takai, et al.
Journal of Periodontal & Implant Science (2025) Vol. 55
Closed Access
The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene TLR4 as a protective factor in corona virus disease 2019 (COVID-19)
Christoph Zacher, Kristina Schönfelder, Hana Rohn, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches
Tudorița Gabriela Părângă, Ivona Mitu, Mariana Pavel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11411-11411
Open Access | Times Cited: 4
Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19
Tetiana Yatsenko, Ricardo A. Rios, Tatiane Nogueira, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Cu encrusted RF sputtered ZnO thin film based electrochemical immunosensor for highly sensitive detection of IL-6 in human blood serum
M. Lakshmi Narayanan, Prabhu Kolandhasamy, N. Ponpandian, et al.
Microchemical Journal (2024) Vol. 199, pp. 110061-110061
Closed Access | Times Cited: 3
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection
Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
SARS-CoV-2 superinfection in CD14+ monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade
Shannon Harger Payen, Kabita Adhikari, Juli Petereit, et al.
Virus Research (2024) Vol. 345, pp. 199375-199375
Open Access | Times Cited: 2
Assessment of COVID-19 risk factors of early and long-term mortality with prediction models of clinical and laboratory variables
Dawid Lipski, Artur Radziemski, Stanisław Wasiliew, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Bioinformatics and systems biology analysis revealed PMID26394986-Compound-10 as potential repurposable drug against covid-19
Haseeb Nisar, Bilal Wajid, Faria Anwar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7972-7985
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top